Semaglutide is used in FDA-approved products for chronic weight management in certain adults with obesity or overweight, and in other products for type 2 diabetes management and certain cardiovascular risk reduction indications
Weight loss in the control group was attributable to the standardised lifestyle counselling, which both groups (treatment and control) received approximately monthly [5]
Dual-agonist incretin peptides from fish with potential for obesity-related type 2 diabetes therapy A review
If this is going on, what's the why behind it
As the elderly population is highly prone to health issues such as Type 2 diabetes, the growing geriatric population is expected to drive the GLP-1 analogues market during the forecast period
For spinal structures with naturally limited blood supply (particularly the intervertebral discs, which are largely avascular), this enhanced circulation to surrounding tissues can make a meaningful difference in healing capacity